Kent & Medway Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long Covid
A Contract Award Notice
by NHS KENT AND MEDWAY INTEGRATED CARE BOARD
- Source
- Find a Tender
- Type
- Contract (Services)
- Duration
- 5 year (est.)
- Value
- £9M
- Sector
- HEALTH
- Published
- 27 Apr 2026
- Delivery
- To 27 Apr 2031 (est.)
- Deadline
- n/a
Related Terms
Location
Maidstone
2 buyers
- NHS Kent & Medway Integrated Care Board Maidstone
1 supplier
- Connect Health Newcastle upon Tyne
Description
NHS Kent & Medway Integrated Care Board have undertaken a Provider Selection Regime (PSR) Competitive Process for a Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long Covid Service in Kent and Medway. The contract duration will be for an initial period of 3 years with an option to extend for up to a further 2 years as required.
Total Quantity or Scope
The contract duration will be for an initial period of 3 years with an option to extend for up to a further 2 years as required.To provide an integrated specialist service for adults (and transitioning young people) with suspected or diagnosed ME/CFS and/or Long Covid across Kent and Medway.Key Features of the Service:• Early diagnosis and personalised care planning• Multidisciplinary team (MDT) approach including medical, nursing, AHPs, and care coordinators• Virtual and in-person support options• Integration with primary care, community services, and voluntary sector• Support for self-management, rehabilitation, and return to work/education• Dedicated pathways for severely affected patients, including home-based care• Transition support for young people moving from paediatric to adult servicesTo provide full end to end pathway for patients with Long Covid & Chronic Fatigue. It includes diagnostics, treatment, rehabilitation and recovery support and delivery of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long Covid to meet the clinic specification in the recently revised national guide for post-COVID syndrome assessment clinics. To support serious debilitating conditions that can follow any type of viral infection. Both conditions have key symptoms in common and there may be similar level of functional impairment in in both. However, there are some important differences that distinguish some people with Long Covid from those with ME/CFS.This contract relates to an existing service with the intention to award being made to a new provider.The contract will commence September 2026 for 3 years with the Commissioner having the optionto extend the Contract for a further 2 years.
Award Detail
| 1 | Connect Health (Newcastle upon Tyne)
|
Renewal Options
Contract may be extended for up to 2 years
Award Criteria
| Social value | 10.0 |
| Quality & Innovation | 30.0 |
| Integration, collaboration & service sustainability | 20.0 |
| Improving access, reducing health inequalities, and facilitating choice | 10.0 |
| Value | 30.0 |
CPV Codes
- 85100000 - Health services
Indicators
- Options are available.
- Award on basis of price and quality.
Other Information
This is a Provider Selection Regime (PSR) intention to award notice.The awarding of this contract is subject to the Health Care Services (Provider SelectionRegime) Regulations 2023. For the avoidance of doubt, the provisions of the ProcurementAct 2023 do not apply to this award. The publication of this notice marks the start of thestandstill period. Representations by providers must be made to the relevant authority by23:59 on the 11th May 2026. This contract has not yet formally been awarded; this noticeserves as an intention to award a contract under the competitive process of the PSR.Written representations should be sent to william.clark7@nhs.net.Award decision-makers - Kent & Medway Executive Sub-CommitteeDate of decision: 27th April 2026Conflicts of Interest: No conflicts of interest raised.The lifetime value of the contract is expected to be £8,969,998The Key Criteria used and weighted by the authority were as follows:Quality and Innovation 30%Value 30%Integration, collaboration, and service sustainability 20%Improving access, reducing health inequalities, and facilitating choice 10%Social value 10%The rationale for this was based on the detailed list of all requirements according to thespecification and requirements of the integrated care system.
Reference
- FTS 037843-2026